All Cosmos Bio-Tech Holding Corp (TW:4148) — Stock Price
All Cosmos Bio-Tech Holding Corp (TW:4148) is currently trading at NT$30.65 TWD, up 1.16% today. Over the past 52 weeks, shares have ranged between NT$29.45 and NT$45.90. This page tracks All Cosmos Bio-Tech Holding Corp's live share price on the TW exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 4148 company net worth.
All Cosmos Bio-Tech Holding Corp (4148) Stock Price Chart — Daily History & Trading Volume
The chart below tracks All Cosmos Bio-Tech Holding Corp's daily closing share price and trading volume on the TW exchange over the past year, giving a clear view of recent price momentum and liquidity.
All Cosmos Bio-Tech Holding Corp Income Statement — Revenue, Profit & Earnings by Year
All Cosmos Bio-Tech Holding Corp's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | NT$2.95 Billion | NT$2.46 Billion | NT$2.83 Billion | NT$3.70 Billion | NT$2.20 Billion |
| Cost of Revenue | NT$2.12 Billion | NT$1.79 Billion | NT$2.24 Billion | NT$2.56 Billion | NT$1.60 Billion |
| Gross Profit | NT$829.47 Million | NT$668.59 Million | NT$587.98 Million | NT$1.14 Billion | NT$594.37 Million |
| Research & Development | NT$4.25 Million | NT$3.74 Million | NT$3.73 Million | NT$2.28 Million | NT$3.85 Million |
| SG&A | NT$288.79 Million | NT$267.74 Million | NT$236.17 Million | NT$229.12 Million | NT$178.22 Million |
| Total Operating Expenses | NT$532.88 Million | NT$504.88 Million | NT$375.99 Million | NT$477.85 Million | NT$381.63 Million |
| Operating Income | NT$296.59 Million | NT$155.88 Million | NT$189.90 Million | NT$645.50 Million | NT$265.62 Million |
| EBITDA | NT$362.56 Million | NT$312.83 Million | NT$310.76 Million | NT$699.84 Million | NT$373.03 Million |
| EBIT | NT$296.59 Million | NT$258.85 Million | NT$261.61 Million | NT$650.83 Million | NT$324.44 Million |
| Interest Expense | NT$14.53 Million | NT$6.08 Million | NT$3.98 Million | NT$18.81 Million | NT$4.54 Million |
| Income Before Tax | NT$297.37 Million | NT$252.77 Million | NT$257.63 Million | NT$633.95 Million | NT$321.58 Million |
| Income Tax Expense | NT$91.14 Million | NT$78.28 Million | NT$68.32 Million | NT$177.93 Million | NT$84.93 Million |
| Net Income | NT$153.00 Million | NT$128.59 Million | NT$139.36 Million | NT$368.20 Million | NT$198.13 Million |
All Cosmos Bio-Tech Holding Corp Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes All Cosmos Bio-Tech Holding Corp's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | NT$4.22 Billion | NT$3.67 Billion | NT$3.67 Billion | NT$4.11 Billion | NT$2.97 Billion |
| Total Current Assets | NT$3.06 Billion | NT$2.66 Billion | NT$2.82 Billion | NT$3.37 Billion | NT$2.30 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | NT$219.03 Million | NT$315.75 Million | NT$198.17 Million | NT$126.69 Million | NT$189.69 Million |
| Net Receivables | NT$883.13 Million | NT$623.08 Million | NT$504.68 Million | NT$727.88 Million | NT$458.04 Million |
| Inventory | NT$683.98 Million | NT$675.03 Million | NT$591.06 Million | NT$1.10 Billion | NT$843.67 Million |
| Property, Plant & Equipment | — | — | — | — | NT$614.56 Million |
| Goodwill | NT$405.00K | NT$383.00K | NT$1.11 Million | NT$364.00K | NT$347.00K |
| Total Liabilities | NT$779.83 Million | NT$540.27 Million | NT$859.54 Million | NT$1.25 Billion | NT$591.28 Million |
| Total Current Liabilities | NT$613.70 Million | NT$478.75 Million | NT$790.25 Million | NT$681.77 Million | NT$562.01 Million |
| Long-term Debt | NT$125.27 Million | NT$15.85 Million | NT$24.80 Million | NT$533.82 Million | NT$0.00 |
| Net Debt | NT$-843.34 Million | NT$-672.32 Million | NT$-915.77 Million | NT$-399.05 Million | NT$-429.13 Million |
| Total Stockholder Equity | NT$2.74 Billion | NT$2.52 Billion | NT$2.25 Billion | NT$2.37 Billion | NT$1.99 Billion |
| Retained Earnings | NT$923.39 Million | NT$652.14 Million | NT$690.10 Million | NT$643.75 Million | NT$523.00 Million |
All Cosmos Bio-Tech Holding Corp Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how All Cosmos Bio-Tech Holding Corp generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | NT$251.93 Million | NT$54.19 Million | NT$959.24 Million | NT$43.84 Million | NT$-67.64 Million |
| Capital Expenditures | NT$42.85 Million | NT$142.25 Million | NT$163.42 Million | NT$60.86 Million | NT$103.85 Million |
| Free Cash Flow | NT$209.08 Million | NT$-88.06 Million | NT$795.82 Million | NT$-17.02 Million | NT$-171.49 Million |
| Investing Cash Flow | NT$-277.80 Million | NT$-228.46 Million | NT$-202.98 Million | NT$-4.67 Million | NT$-108.17 Million |
| Financing Cash Flow | NT$82.94 Million | NT$-428.49 Million | NT$-549.88 Million | NT$490.39 Million | NT$196.10 Million |
| Dividends Paid | NT$32.02 Million | NT$64.03 Million | NT$160.09 Million | NT$96.05 Million | NT$64.03 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | NT$65.97 Million | NT$53.98 Million | NT$49.15 Million | NT$49.01 Million | NT$48.59 Million |
| Change in Cash | NT$146.61 Million | NT$-524.93 Million | NT$117.35 Million | NT$601.07 Million | NT$-21.37 Million |
All Cosmos Bio-Tech Holding Corp Earnings History — EPS Actual vs. Analyst Estimates
Track All Cosmos Bio-Tech Holding Corp's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 13, 2025 | — | — | — |
| Nov 13, 2024 | 1.08 | 0.49 | +120.41% |
| Aug 29, 2024 | 0.11 | 0.43 | -74.42% |
| Mar 14, 2024 | -0.13 | — | — |
| Nov 10, 2023 | 1.07 | — | — |
| Aug 25, 2023 | 0.42 | — | — |
| May 12, 2023 | 0.60 | 0.92 | -34.78% |
| Mar 22, 2023 | 0.73 | 1.12 | -34.82% |